Valion Bio, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
4.15M
on 2026-06-30, from 87K on 2024-03-31 10-Q ↗
Earlier counts are adjusted for the 1-for-17 reverse split; each bar's tip shows the count as filed.
a raise that quarter, at its price
Newest
None
No S-3 or F-3 shelf on file in the last 30 months.
$25.0M
Mast Hill Fund, agreement of 2025-12-09. No at-the-market sales statement read from a 10-Q or 10-K. 8-K ↗
Cash
0.6 quarters
$2.1M on 2026-06-30 ÷ $3.6M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-09-01 | Private placement | 3,077 | not read | $7.7M | 8-K ↗ |
| 2026-08-17 | Private placement | not read | not read | $1.5M | 8-K ↗ |